Health
BioNTech, Pfizer file for EU approval of COVID-19 vaccine – CGTN
On Tuesday, Germany’s BioNTech and its U.S. partner Pfizer said they had applied for EU regulatory approval for their COVID-19 vaccine, raising hopes that the first jabs could be administered in December.
The two companies said in a statement that they had submitted an application to the European Medicines Agency on Monday “for Conditional Marketing Authorization (CMA)” for their vaccine after tests showed it was 95 percent effective against the novel coronavirus.
If approved, the jab could potentially…
-
Noosa News15 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General13 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
General13 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News14 hours agoLyka Doggie Date Night at Moonlight Cinema